Health News Archive - May 13, 2010
EXTON, Pa., May 13 /PRNewswire-FirstCall/ -- Fibrocell Science, Inc.
BEDFORD, Mass., May 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that it will present at four investor conferences in May and June 2010. The conferences and presentation dates and times (Eastern) are as follows: May 26, 2010 at 9:00 a.m.
Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.
Sales rise 17% for the Toronto biotech which is now focused on partnering its pipeline TORONTO, May 13 /PRNewswire-FirstCall/ - Microbix Biosystems Inc.
In the first randomized trial of art therapy for asthma, National Jewish Health researchers found that children with persistent asthma enjoyed decreased anxiety and increased quality of life after seven weekly art-therapy sessions.
TIANJIN, China, May 13 /PRNewswire-Asia/ -- A signing ceremony for a strategic partnership agreement between Tianjin International Joint Academy of Biotechnology and Medicine (TJAB) and Genzyme Corporation was held in the Tianjin Economic-Technological Development Area (TEDA) on 10 May. Officials and executives including Rao Zihe, President of TJAB and President of Nankai University, He Shushan, Director of TEDA Administrative Commission and Standing Committee Member of the CPC Committee of the Binhai New Area, Li Baochun, Deputy Director of the Tianjin Municipal Science and Technology Commission, Huang Yalou, Director of the Binhai New Area Science and Technology Commission, Zhang Yaozhou, Vice president of TJAB, Richard Gregory, Senior VP and Head of Research, Genzyme, Canwen Jiang, Vice President and Head of R&D Asia, Genzyme, and Shan Jizhong, General Manager of Genzyme Beijing Biotechnology Co.
HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Mr.
HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc.
PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.
ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners.